BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16575003)

  • 1. Translocation carcinomas of the kidney after chemotherapy in childhood.
    Argani P; Laé M; Ballard ET; Amin M; Manivel C; Hutchinson B; Reuter VE; Ladanyi M
    J Clin Oncol; 2006 Apr; 24(10):1529-34. PubMed ID: 16575003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
    Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas.
    Medendorp K; van Groningen JJ; Schepens M; Vreede L; Thijssen J; Schoenmakers EF; van den Hurk WH; Geurts van Kessel A; Kuiper RP
    Cytogenet Genome Res; 2007; 118(2-4):157-65. PubMed ID: 18000366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient.
    Pecciarini L; Cangi MG; Lo Cunsolo C; Macri' E; Dal Cin E; Martignoni G; Doglioni C
    Genes Chromosomes Cancer; 2007 May; 46(5):419-26. PubMed ID: 17285572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal carcinoma associated with MiTF/TFE translocation: report of six cases in young adults].
    Hintzy MC; Camparo P; Vasiliu V; Peyromaure M; Vieillefond A
    Prog Urol; 2008 May; 18(5):275-80. PubMed ID: 18538271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family.
    Ramphal R; Pappo A; Zielenska M; Grant R; Ngan BY
    Am J Clin Pathol; 2006 Sep; 126(3):349-64. PubMed ID: 16880148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
    Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
    Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocation carcinomas of the kidney.
    Argani P; Ladanyi M
    Clin Lab Med; 2005 Jun; 25(2):363-78. PubMed ID: 15848741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
    Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
    Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
    Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
    Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome.
    Mir MC; Trilla E; de Torres IM; Panizo A; Zlotta AR; Van Rhijn B; Morote J
    BJU Int; 2011 Jul; 108(2 Pt 2):E71-6. PubMed ID: 21070573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy.
    Rais-Bahrami S; Drabick JJ; De Marzo AM; Hicks J; Ho C; Caroe AE; Argani P
    Urology; 2007 Jul; 70(1):178.e3-6. PubMed ID: 17656236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
    Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
    Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels.
    Kuroda N; Tamura M; Tanaka Y; Hes O; Michal M; Inoue K; Ohara M; Mizuno K; Lee GH
    Pathol Int; 2009 Jul; 59(7):486-91. PubMed ID: 19563413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation.
    Inamura K; Fujiwara M; Togashi Y; Nomura K; Mukai H; Fujii Y; Yamamoto S; Yonese J; Fukui I; Ishikawa Y
    Am J Surg Pathol; 2012 Jan; 36(1):35-42. PubMed ID: 22173116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.
    Komai Y; Fujiwara M; Fujii Y; Mukai H; Yonese J; Kawakami S; Yamamoto S; Migita T; Ishikawa Y; Kurata M; Nakamura T; Fukui I
    Clin Cancer Res; 2009 Feb; 15(4):1170-6. PubMed ID: 19228722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
    Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
    Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
    Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
    Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.